ROR?t inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating ?d-T cells.
ROR?t inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating ?d-T cells. Rheumatology (Oxford). 2023 09 01; 62(9):3169-3178.